Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 22, 2005
Reporting Period: Thirteen and fifty-two weeks ended May 28, 2005.
This filing serves to disclose the company's financial results for the specified periods via a press release attached as Exhibit 99.1. The 8-K itself does not contain the detailed financial data but incorporates the press release by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms that results for the thirteen and fifty-two weeks ended May 28, 2005, were announced.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the body of this 8-K filing. Such information, if present, would be located in the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and earnings per share figures for the 13 and 52 weeks ended May 28, 2005.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking statements or guidance updates included in the press release.
- Confirm the company's cash position and debt levels as reported in the full financial statements referenced by the press release.